1. Montealegre, Sebastian, Lebigot, Elise, Debruge, Hugo, Gitiaux, Cyril, de Lonlay, Pascale. 2022. FDX2 and ISCU Gene Variations Lead to Rhabdomyolysis With Distinct Severity and Iron Regulation. In Neurology. Genetics, 8, e648. doi:10.1212/NXG.0000000000000648. https://pubmed.ncbi.nlm.nih.gov/35079622/
2. Zhao, Xueying, Chen, Jin, Yin, Shangqi, Yuan, Zhengrong, Wang, Yajie. 2022. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis. In Frontiers in oncology, 12, 992468. doi:10.3389/fonc.2022.992468. https://pubmed.ncbi.nlm.nih.gov/36313717/
3. Dreishpoon, Margaret B, Bick, Nolan R, Petrova, Boryana, Golub, Todd R, Tsvetkov, Peter. 2023. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. In The Journal of biological chemistry, 299, 105046. doi:10.1016/j.jbc.2023.105046. https://pubmed.ncbi.nlm.nih.gov/37453661/
4. Joshi, Pallavi R, Sadre, Shayan, Guo, Xiaoyan A, McCoy, Jason G, Mootha, Vamsi K. 2023. Lipoylation is dependent on the ferredoxin FDX1 and dispensable under hypoxia in human cells. In The Journal of biological chemistry, 299, 105075. doi:10.1016/j.jbc.2023.105075. https://pubmed.ncbi.nlm.nih.gov/37481209/
5. Gurgel-Giannetti, Juliana, Lynch, David S, Paiva, Anderson Rodrigues Brandão de, Houlden, Henry, Kok, Fernando. . A novel complex neurological phenotype due to a homozygous mutation in FDX2. In Brain : a journal of neurology, 141, 2289-2298. doi:10.1093/brain/awy172. https://pubmed.ncbi.nlm.nih.gov/30010796/
智鼠故事 
